TG Therapeutics Inc (TGTX)
Gross profit margin
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Gross profit | US$ in thousands | 84,210 | -67,434 | -121,613 | -107,698 | -14,875 |
| Revenue | US$ in thousands | 221,047 | 2,785 | 6,689 | 152 | 152 |
| Gross profit margin | 38.10% | -2,421.33% | -1,818.10% | -70,853.95% | -9,786.18% |
December 31, 2023 calculation
Gross profit margin = Gross profit ÷ Revenue
= $84,210K ÷ $221,047K
= 38.10%
The gross profit margin of TG Therapeutics Inc has exhibited significant fluctuations over the past five years. In 2023, the gross profit margin improved to 38.10%, indicating that the company generated 38.10 cents of gross profit for every dollar of revenue after accounting for the cost of goods sold.
However, in 2022 and 2021, the gross profit margin was negative, reflecting that the company's cost of goods sold exceeded its revenue, resulting in losses at the gross profit level. This negative trend was particularly pronounced in 2020 and 2019, with gross profit margins of -70,853.95% and -9,786.18% respectively, highlighting significant operational inefficiencies and challenges in generating profits from sales.
The positive improvement in the gross profit margin in 2023 compared to the prior years suggests potential operational enhancements or changes in the product mix that have positively impacted the company's ability to generate profits on its sales. Overall, the company's gross profit margin performance indicates the importance of closely monitoring and managing costs to ensure sustainable profitability and financial health.
Peer comparison
Dec 31, 2023